These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14175615)

  • 21. Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.
    Han C; Hui Q; Wang Y
    Nat Prod Res; 2008; 22(13):1112-9. PubMed ID: 18855210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EXPERIMENTAL DIABETES AND THE MODE OF ACTION OF THE SULFONYLUREAS. WITH SOME SPECULATIONS ON THE PREVENTION OF DIABETES.
    FOA PP
    Bull Sinai Hosp Detroit; 1964; 12():31-46. PubMed ID: 14156394
    [No Abstract]   [Full Text] [Related]  

  • 23. NOVEL ORAL HYPOGLYCEMIC AGENTS. I. HEXAHYDROINDENO(1,2-C)PYRROLES AND INDANAMINES.
    LAHIRI SC; PATHAK B
    J Med Chem; 1965 Jan; 8():131-3. PubMed ID: 14289822
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats.
    Singh N; Gupta M; Sirohi P; Varsha
    J Environ Biol; 2008 Jan; 29(1):101-6. PubMed ID: 18831340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging Trends On Drug Delivery Strategy of Momordica charantia against Diabetes and its Complications.
    Thent ZC; Das S; Zaidun NH
    Curr Drug Deliv; 2018; 15(4):453-460. PubMed ID: 28545355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolbutamide and the onset of alloxan diabetes in rats.
    KLIMAS JE; SEARLE GW
    Diabetes; 1958; 7(5):388-92. PubMed ID: 13574027
    [No Abstract]   [Full Text] [Related]  

  • 27. Tandem multimer expression and preparation of hypoglycemic peptide MC6 from Momordica charantia in Escherichia coli.
    Wang FJ; Song HL; Wang XM; Zhang WJ; Wang BL; Zhao J; Hu ZB
    Appl Biochem Biotechnol; 2012 Feb; 166(3):612-9. PubMed ID: 22101446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A NEW HYPOGLYCEMIC COMPOUND, 1-CYCLOHEXYL-3-(5-INDANYLSULFONYL) UREA.
    LERNER LJ; BIANCHI A; BORMAN A
    Metabolism; 1965 May; 14():578-82. PubMed ID: 14289483
    [No Abstract]   [Full Text] [Related]  

  • 29. Study of the anti-hyperglycemic effect of plants used as antidiabetics.
    Alarcon-Aguilara FJ; Roman-Ramos R; Perez-Gutierrez S; Aguilar-Contreras A; Contreras-Weber CC; Flores-Saenz JL
    J Ethnopharmacol; 1998 Jun; 61(2):101-10. PubMed ID: 9683340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION].
    STERNE J; HIRSCH C
    Diabete; 1964; 12():171-5. PubMed ID: 14173920
    [No Abstract]   [Full Text] [Related]  

  • 31. Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects.
    Chaturvedi P
    J Med Food; 2012 Feb; 15(2):101-7. PubMed ID: 22191631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice.
    Bailey CJ; Day C; Turner SL; Leatherdale BA
    Diabetes Res; 1985 Mar; 2(2):81-4. PubMed ID: 3899464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EXPERIMENTAL STUDY OF THE ANTI-ALCOHOL ACTION OF VARIOUS SUBSTANCES].
    ROYER R; LAMARCHE M
    J Physiol (Paris); 1964; 56():437-8. PubMed ID: 14219854
    [No Abstract]   [Full Text] [Related]  

  • 34. [PHARMACOLOGY OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING COMPOUND].
    KRAMER M; HECHT G; LANGECKER H; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():377-85. PubMed ID: 14238594
    [No Abstract]   [Full Text] [Related]  

  • 35. EXPERIMENTAL STUDIES ON PITUITARY DIABETES. III. EFFECT OF INDIGENOUS ANTI-DIABETIC DRUGS AGAINST THE ACUTE HYPERGLYCAEMIC RESPONSE OF ANTERIOR PITUITARY EXTRACT IN GLUCOSE FED ALBINO RATS.
    GUPTA SS
    Indian J Med Res; 1963 Jul; 51():716-24. PubMed ID: 14073626
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoglycaemic activity of dioscoretine from tubers of Dioscorea dumetorum in normal and alloxan diabetic rabbits.
    Iwu MM; Okunji CO; Ohiaeri GO; Akah P; Corley D; Tempesta MS
    Planta Med; 1990 Jun; 56(3):264-7. PubMed ID: 2392490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice.
    Malik ZA; Singh M; Sharma PL
    J Ethnopharmacol; 2011 Jan; 133(2):729-34. PubMed ID: 21056650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of the post-absorptive state to the hypoglycemic action studies on Ficus bengalensis and Ficus glomerata.
    SHROTRI DS; AIMAN R
    Indian J Med Res; 1960 Mar; 48():162-8. PubMed ID: 14446232
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of bittergourd (Momordica charantia) seed & glibenclamide in streptozotocin induced diabetes mellitus.
    Kedar P; Chakrabarti CH
    Indian J Exp Biol; 1982 Mar; 20(3):232-5. PubMed ID: 6811427
    [No Abstract]   [Full Text] [Related]  

  • 40. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
    Ma C; Yu H; Xiao Y; Wang H
    Pharm Biol; 2017 Dec; 55(1):2170-2177. PubMed ID: 29110587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.